Tempsens Instruments’ IPO grey market premium (GMP) rises above 100% as the issue moves through its final subscription days, with some reports citing a GMP that implies a roughly 104% potential listing gain. NDTV separately compares the expected listing prospects of Tempsens with those of Augmont Enterprises, reporting Augmont’s GMP at about 48%. Both IPOs are described as drawing investor interest, with Tempsens notably outperforming in the grey market.
Economic Times says Tempsens is among the first IPOs in nearly two years to cross the 100% premium milestone, and links the move to strong subscription momentum. It reports the IPO has been subscribed nearly 22 times on its second day, and highlights that other upcoming IPOs also show strengthening grey market premiums, suggesting renewed investor appetite. NDTV also reports very high subscription levels approaching the final day, and frames the GMP as indicating a potential listing gain around the 104% range.
Across outlets, the main difference is timing and figures: some cite values for the GMP and subscription on specific days, but the shared point is that Tempsens’ IPO is showing stronger grey market traction than Augmont’s.
